Genetic test helps predict risk of prostate cancer recurrence
(Medical Xpress)—Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment.
Cancer
May 10, 2013 |
not rated yet |
0
Taking cholesterol-lowering drugs may also reduce the risk of dying from prostate cancer, study finds
Men with prostate cancer who take cholesterol-lowering drugs called statins are significantly less likely to die from their cancer than men who don't take such medication, according to study led by researchers at Fred Hutchinson ...
Cancer
May 02, 2013 |
not rated yet |
1
Using genetic variants to improve PSA testing technique and reduce biopsies
With the help of genetics, prostate specific antigen (PSA) screenings may become more accurate and reduce the number of unnecessary prostate biopsies, according to a new study from Northwestern Medicine.
Cancer
Apr 24, 2013 |
5 / 5 (1) |
0
Nearly half of all deaths from prostate cancer can be predicted before age 50
Focusing prostate cancer testing on men at highest risk of developing the disease is likely to improve the ratio between benefits and the harms of screening, suggests a paper published today in BMJ.
Cancer
Apr 16, 2013 |
5 / 5 (2) |
0
Study questions value of PSA test for older men
(HealthDay)—Only one-third of men over age 65 who receive an abnormal result from their PSA test actually undergo prostate biopsy to look for disease, a new study finds.
Cancer
Apr 15, 2013 |
not rated yet |
0
|
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for th ...
Cancer
Apr 15, 2013 |
not rated yet |
0
On-and-off approach to prostate cancer treatment may compromise survival
Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study finds.
Cancer
Apr 03, 2013 |
not rated yet |
0
|
Digital rectal exam remains important part of prostate screening
(Medical Xpress)—The digital rectal exam is an important screening test that can discover prostate cancer that a prostate-specific antigen or PSA test may not, despite the higher sensitivity of the PSA test, according to ...
Cancer
Mar 18, 2013 |
not rated yet |
0
|
New genetic test can predict man's risk of developing prostate cancer
Researchers in Japan have created a genetic test that will help doctors diagnose prostate cancer. When given together with testing for prostate specific antigen (PSA), a widely used diagnostic biomarker for ...
Cancer
Feb 08, 2013 |
5 / 5 (3) |
0
|
Alternative PSA screening strategies could reduce harm
(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary ...
Cancer
Feb 05, 2013 |
not rated yet |
0
Updated 'Partin Tables' tool now available to predict prostate cancer spread
Prostate cancer experts at Johns Hopkins have developed an updated version of the Partin Tables, a tool to help men diagnosed with prostate cancer and their doctors to better assess their chance of a surgical cure. The updated ...
Cancer
Jan 04, 2013 |
not rated yet |
0
Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent ...
Cancer
Nov 08, 2012 |
5 / 5 (2) |
0
Drop in testosterone tied to prostate cancer recurrence
Men whose testosterone drops following radiation therapy for prostate cancer are more likely to experience a change in PSA levels that signals their cancer has returned, according to new research from Fox Chase Cancer Center. ...
Cancer
Oct 28, 2012 |
3.5 / 5 (2) |
0
Taking breaks from prostate cancer hormone therapy seems safe: study
(HealthDay)—Stop-and-start hormone-deprivation therapy for localized prostate cancer doesn't shorten overall survival compared to continuous treatments, and yields fewer side effects such as impotence and ...
Cancer
Sep 05, 2012 |
not rated yet |
0
|
Doctors can now detect hard-to-diagnose prostate cancer
Researchers have successfully developed and tested a new prostate cancer screening method that uses the combined power of a novel drug therapy and changes in PSA levels over time to identify men with a high PSA who are more ...
Cancer
Aug 09, 2012 |
5 / 5 (1) |
0
